Pyrimido 4,5-b indole derivatives
CA 2464934 A1 · Owner: Shimazaki, Makoto · Inventors: Komura, Hiroshi; Yamamoto, Masaru; Nakashima, Kosuke
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to pyrimido4,5-bindoles which are useful as an active ingredient of pharmaceutical preparations. The pyrimido4,5-bindoles of the present invention have MKK7 and MKK4 inhibitory activity and can be , used for the prophylaxis and treatment of diseases associated with MKK7 and MKK4 activity. Such diseases include, inflammatory and immunoregulatory disorders and diseases such as asthma, atopic dermatitis rhinitis, allergic , rhinitis, allergic diseases COPD, septic shock, arthritis, joint diseases and myocardial injuries, as well as autoimmune pathologies such as rheumatoid arthritis, Grave's disease, and atherosclerosis. The compounds of the present …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.